NXTS
Nexentis Technologies Inc. Common Stock (NXTS)
Basic Materials • NASDAQ • $5.11-12.65%
- Symbol
- NXTS
- Exchange
- NASDAQ
- Sector
- Basic Materials
- Industry
- Agricultural Inputs
- Price
- $5.11
- Daily Change
- -12.65%
- Market Cap
- $3.73M
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $109.03
- 52W Low
- $3.38
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 1.74
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
Company websiteResearch NXTS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.